A low factor VIII activity test means the blood has less working factor VIII than expected. Factor VIII is a clotting protein that helps form a stable blood clot after injury, surgery, dental work, childbirth, or internal bleeding. A low result matters because it raises the chance of prolonged, delayed, or repeated bleeding, especially when the level is very low. The best-known cause is hemophilia A, an inherited factor VIII deficiency, but low factor VIII also occurs with von Willebrand disease, acquired factor VIII inhibitors, major bleeding, severe illness, and some laboratory or medication-related problems.
The result needs interpretation with the bleeding history, family history, aPTT, von Willebrand factor tests, and sometimes genetic or inhibitor testing. A mildly low value does not always mean severe disease, and a normal or near-normal value does not always rule out a bleeding disorder if symptoms are convincing.
- Low factor VIII activity usually means reduced clotting ability, most often from hemophilia A, von Willebrand disease, or an acquired inhibitor.
- Many labs consider factor VIII activity roughly 50% to 150% normal, but each laboratory sets its own reference range.
- Hemophilia A severity is often grouped by factor VIII level: severe under 1%, moderate 1% to 5%, and mild above 5% to under 40%.
- Bleeding risk rises most when factor VIII is below 40%, but personal bleeding history often predicts risk better than one number alone.
- Low factor VIII often prolongs aPTT, while PT/INR is usually normal unless another clotting problem is present.
- Urgent care is needed for head injury, neck/throat swelling, severe abdominal pain, black stools, blood in urine, or uncontrolled bleeding.
Table of Contents
- What Low Factor VIII Activity Means
- Normal Range and Severity Levels
- Common Causes of Low Factor VIII
- Bleeding Symptoms and Risk
- How the Test Is Done and What Affects Results
- Follow-Up Tests After a Low Result
- Treatment, Safety, and Practical Next Steps
- Special Situations
What Low Factor VIII Activity Means
Low factor VIII activity means the laboratory found reduced working activity of clotting factor VIII in the blood sample. The test does not simply count how much factor VIII protein is present. It measures how well factor VIII performs in the clotting process.
Factor VIII works in the “intrinsic” clotting pathway, where it helps activated factor IX turn on factor X. That step supports thrombin formation, fibrin formation, and a stable clot. When factor VIII activity is low, clots form more slowly and break down before the injury has fully sealed.
A low result is most important when it matches a bleeding pattern such as:
- Bleeding for a long time after dental extraction, surgery, circumcision, childbirth, or injury
- Bleeding that stops, then starts again hours or days later
- Large deep bruises or muscle hematomas
- Joint swelling, warmth, stiffness, or pain from bleeding into a joint
- Heavy menstrual bleeding starting at the first periods
- Recurrent nosebleeds, mouth bleeding, blood in urine, or gastrointestinal bleeding
Factor VIII is closely linked to von Willebrand factor, often shortened to vWF. Von Willebrand factor carries factor VIII in the bloodstream and protects it from being cleared too quickly. Because of this relationship, a low factor VIII activity result does not automatically mean hemophilia A. A low von Willebrand factor level or abnormal vWF function also lowers factor VIII.
Low factor VIII mainly causes a bleeding tendency, not a clotting tendency. This is different from a high factor VIII activity result, which is more often discussed in relation to inflammation and blood clot risk.
A single low result gives a clue, not a complete diagnosis. The next step is to confirm whether the low activity is persistent, inherited, acquired, caused by von Willebrand disease, or caused by an inhibitor that blocks factor VIII.
Normal Range and Severity Levels
Many laboratories report factor VIII activity as a percentage of normal pooled plasma or as IU/dL. In practical use, 1 IU/dL is treated as about 1% activity. A result of 30 IU/dL usually means about 30% factor VIII activity.
Most labs use a reference range around 50% to 150%, though some use slightly wider ranges such as 50% to 200%. The exact normal range depends on the assay method, reagent, instrument, age group, and laboratory validation.
The most useful interpretation is not only “low” or “normal.” The actual percentage matters because bleeding risk changes as the level falls.
| Factor VIII activity | Common interpretation | Typical bleeding pattern |
|---|---|---|
| About 50% to 150% | Often within the adult reference range | Bleeding disorder less likely, but symptoms still matter |
| 40% to 50% | Borderline or mildly reduced in many labs | Bleeding risk varies; repeat testing and vWF testing often matter |
| Above 5% to under 40% | Mild hemophilia A range when vWF is normal | Bleeding usually follows surgery, dental work, childbirth, or major injury |
| 1% to 5% | Moderate hemophilia A range | Bleeding after minor injury; some spontaneous joint or muscle bleeding |
| Under 1% | Severe hemophilia A range | Frequent spontaneous joint, muscle, and internal bleeding without prevention |
These ranges are widely used, but they do not replace clinical judgment. Two people with the same factor VIII activity value can bleed differently. Joint health, age, activity level, prior bleeds, other clotting factors, platelet function, medications, and vWF levels all affect real-world risk.
Mild hemophilia A is easy to miss. A person with 20% to 35% activity can go years without major bleeding, then bleed excessively after wisdom tooth extraction, tonsil surgery, childbirth, trauma, or an operation. Some people first learn they have mild hemophilia A in adulthood.
A low-normal factor VIII result also needs caution when symptoms are strong. Some mild hemophilia A variants show different results depending on whether the lab uses a one-stage clotting assay or a chromogenic factor VIII assay. When bleeding history and test results do not fit, repeating testing with both methods is often useful. A related baseline article on factor VIII activity normal range can help place borderline results in context.
Common Causes of Low Factor VIII
Low factor VIII has several important causes. The most likely cause depends on age, sex, family history, bleeding pattern, other clotting tests, pregnancy status, medications, and whether the result appeared suddenly or has been present before.
Hemophilia A
Hemophilia A is an inherited factor VIII deficiency caused by a change in the F8 gene. It is usually X-linked, so it classically affects males, but females and people assigned female at birth can also have low factor VIII and clinically important bleeding.
Hemophilia A becomes more likely when factor VIII is low, von Willebrand factor antigen and activity are normal, and the bleeding pattern includes deep bruising, joint bleeding, muscle bleeding, or prolonged bleeding after procedures. A family history strengthens the suspicion, but many cases appear without a known family history because new F8 gene variants occur.
Severe hemophilia A often appears in infancy or early childhood. Mild hemophilia A often appears later, especially after dental work, surgery, childbirth, or injury.
Von Willebrand disease
Von Willebrand disease is a common inherited bleeding disorder that affects von Willebrand factor level or function. Because von Willebrand factor stabilizes factor VIII, a low vWF level or poor vWF function can lower factor VIII activity.
This distinction matters because hemophilia A and von Willebrand disease have overlapping but different testing and treatment plans. Von Willebrand disease more often causes mucosal bleeding, such as nosebleeds, gum bleeding, easy bruising, heavy periods, and postpartum bleeding. Some types also cause low factor VIII that resembles mild or moderate hemophilia A.
A von Willebrand disease panel usually includes vWF antigen, vWF activity, and factor VIII activity to help separate these conditions.
Acquired factor VIII inhibitor
An acquired factor VIII inhibitor is an antibody that blocks factor VIII. This condition is often called acquired hemophilia A. It is not the same as inherited hemophilia A.
Acquired hemophilia A usually starts suddenly in a person with no lifelong bleeding history. It often causes large skin bruises, muscle bleeding, soft tissue bleeding, gastrointestinal bleeding, urinary bleeding, or severe bleeding after a procedure. Joint bleeding is less typical than in inherited severe hemophilia A.
This condition is rare but dangerous. It occurs more often in older adults, postpartum patients, and people with autoimmune disease, cancer, certain infections, or medication exposures. In many cases, no trigger is found. The lab pattern often shows a prolonged aPTT, very low factor VIII activity, and a mixing study that does not fully correct.
Combined factor problems and severe illness
Factor VIII does not usually fall from vitamin K deficiency alone. Vitamin K mainly affects factors II, VII, IX, and X. That is why isolated low factor VIII points more toward hemophilia A, von Willebrand disease, an inhibitor, or assay-related issues than simple vitamin K deficiency.
Factor VIII can become low in broader clotting problems, especially when the body consumes clotting factors during severe bleeding, disseminated intravascular coagulation, massive transfusion, or critical illness. In those settings, other tests are usually abnormal too, such as platelet count, PT/INR, fibrinogen, and D-dimer. A broad coagulation panel helps show whether the problem is isolated or part of a wider clotting disorder.
Severe liver disease can disturb many clotting proteins, but factor VIII often stays normal or rises because it is also produced outside liver cells and behaves as an acute-phase reactant. A low factor VIII result in liver disease needs careful review rather than automatic attribution to the liver.
Testing, sample, and medication effects
Some low results come from technical or medication-related factors. A blood sample that is underfilled, clotted, mishandled, delayed too long before processing, or drawn from a heparin-contaminated line can give misleading coagulation results.
Anticoagulant medicines also complicate interpretation. Heparin, direct thrombin inhibitors, and some direct oral anticoagulants can interfere with clot-based assays. Warfarin does not directly lower factor VIII, but it changes other clotting tests. The laboratory and clinician need to know about anticoagulants before interpreting a low activity result.
| Cause | Clue that supports it | Typical next test |
|---|---|---|
| Hemophilia A | Low factor VIII with normal vWF; family history or deep tissue bleeding | Repeat factor VIII, chromogenic assay, F8 genetic testing |
| Von Willebrand disease | Nosebleeds, heavy periods, mucosal bleeding, low vWF markers | vWF antigen, vWF activity, factor VIII, multimer or subtype testing |
| Acquired factor VIII inhibitor | Sudden severe bleeding, prolonged aPTT, no lifelong bleeding history | Mixing study, Bethesda inhibitor assay |
| Consumption or critical illness | Multiple abnormal clotting tests, low fibrinogen or platelets | PT/INR, aPTT, fibrinogen, D-dimer, platelet count |
| Assay or sample issue | Unexpected result that does not match symptoms | Repeat sample, review medication and collection details |
Bleeding Symptoms and Risk
Bleeding risk rises as factor VIII falls, but the number alone does not tell the whole story. A person with severe hemophilia A has a high risk of spontaneous bleeding without preventive treatment. A person with mild hemophilia A might feel well in daily life but face serious bleeding during surgery, dental extraction, childbirth, or trauma.
The most concerning bleeding patterns include:
- Joint bleeding: pain, warmth, swelling, stiffness, reduced motion, limping, or a “bubbling” feeling inside a joint
- Muscle bleeding: deep pain, swelling, tightness, numbness, weakness, or pressure symptoms
- Head or brain bleeding: headache, vomiting, confusion, sleepiness, weakness, seizure, vision changes, or symptoms after a head injury
- Neck, throat, or mouth bleeding: swelling, trouble swallowing, voice changes, breathing difficulty, or expanding bruising
- Abdominal or gastrointestinal bleeding: severe belly pain, black stools, red blood in stool, vomiting blood, dizziness, or fainting
- Urinary tract bleeding: red or brown urine, clots in urine, flank pain, or trouble passing urine
- Gynecologic bleeding: very heavy periods, soaking protection quickly, large clots, anemia symptoms, or delayed postpartum bleeding
Small surface cuts do not always reveal a factor VIII problem because pressure often stops them. Hemophilia bleeding is more often deep, delayed, recurrent, or out of proportion to the injury.
Bleeding history carries special weight. A person who has bled heavily after several procedures needs a full evaluation even if the first factor VIII value is only mildly low or borderline. A person with a low factor VIII value but no bleeding history still needs review before surgery, dental extraction, childbirth, or high-risk activities.
The aPTT test often becomes prolonged when factor VIII is very low. Mild hemophilia A can have a normal or only slightly high aPTT, depending on the reagent and the person’s factor VIII level. A normal screening test therefore does not always rule out mild disease. A more focused page on high aPTT causes and bleeding risk explains how prolonged intrinsic-pathway testing fits into the workup.
People with low factor VIII should treat head injuries seriously. Even a seemingly minor head impact needs medical advice when factor VIII is very low, when the person has a known bleeding disorder, or when symptoms appear afterward. Brain bleeding is uncommon compared with bruises or joint bleeds, but it is the bleeding emergency doctors work hardest to prevent.
How the Test Is Done and What Affects Results
The factor VIII activity test uses a blood sample, usually collected into a blue-top sodium citrate tube. The citrate prevents clotting in the tube so the lab can measure clotting activity under controlled conditions.
No fasting is usually required. The most important preparation is giving the clinician and laboratory accurate information about:
- Current anticoagulants, including heparin, warfarin, apixaban, rivaroxaban, dabigatran, or edoxaban
- Recent factor VIII treatment, desmopressin, emicizumab, or bypassing agents
- Recent surgery, bleeding, transfusion, pregnancy, childbirth, infection, or inflammation
- Estrogen therapy, hormonal contraception, or fertility treatment
- Prior abnormal clotting tests or known family bleeding disorders
Do not stop prescribed blood thinners or bleeding-disorder treatment unless the prescribing clinician gives direct instructions. Stopping the wrong medication before testing can cause harm.
One-stage and chromogenic factor VIII assays
Laboratories often measure factor VIII activity with a one-stage clotting assay. This method is common and useful, but it is not perfect for every patient.
A chromogenic factor VIII assay uses a different method based on factor X activation. It is especially helpful when the bleeding history and one-stage factor VIII result do not match. Some mild hemophilia A variants give different results between the two assays. Some treatments also require specific assay choices for accurate monitoring.
When a person has a strong bleeding history, a near-normal one-stage result should not end the investigation automatically. A hematologist may order both assay types.
Factor VIII changes with stress and inflammation
Factor VIII is an acute-phase reactant, meaning levels often rise during inflammation, infection, physical stress, surgery, pregnancy, and estrogen exposure. This rise can temporarily hide a mild baseline deficiency.
For example, someone with a usual factor VIII level near 35% might test closer to normal during pregnancy, acute illness, or right after an injury. That does not prove the person has no inherited tendency. Repeat testing when well and not pregnant often gives a clearer baseline.
Blood type also affects von Willebrand factor and factor VIII. People with blood type O tend to have lower vWF levels on average, which can also lower factor VIII. This does not by itself diagnose a bleeding disorder, but it helps explain some borderline patterns.
Sample quality matters
Coagulation tests are sensitive to collection details. An underfilled citrate tube changes the blood-to-anticoagulant ratio. A clotted sample cannot be used reliably. Blood drawn through a line flushed with heparin can cause misleading clotting results. Long transport delays or poor processing can also affect factor activity.
If the result is unexpected, repeating the test from a clean venipuncture is often the safest first step. This is especially true when the result does not match the person’s bleeding history, aPTT, or previous records.
Follow-Up Tests After a Low Result
Follow-up testing should answer four questions: Is the result real? Is it inherited or acquired? Is von Willebrand factor involved? Is an inhibitor blocking factor VIII?
A typical workup includes several tests rather than one repeat factor VIII value.
| Test | Why it helps |
|---|---|
| Repeat factor VIII activity | Confirms the result and checks whether the level is persistent |
| aPTT | Screens the intrinsic pathway where factor VIII works |
| PT/INR | Looks for broader clotting problems outside isolated factor VIII deficiency |
| CBC and platelet count | Checks anemia from bleeding and platelet-related causes of bleeding |
| vWF antigen and vWF activity | Identifies von Willebrand disease patterns that lower factor VIII |
| Mixing study | Helps separate factor deficiency from an inhibitor |
| Bethesda or Nijmegen-Bethesda inhibitor assay | Measures factor VIII inhibitor strength when suspected |
| Chromogenic factor VIII assay | Clarifies assay discrepancies and some mild hemophilia A variants |
| F8 genetic testing | Confirms inherited hemophilia A and helps family testing |
A mixing study is especially important when factor VIII is very low or the aPTT is prolonged. In a mixing study, the patient’s plasma is mixed with normal plasma. If the clotting time corrects, a factor deficiency is more likely. If it does not correct, or correction fades after incubation, an inhibitor becomes more likely.
Testing for von Willebrand disease is not optional when factor VIII is low without a clear diagnosis. Type 1 von Willebrand disease can cause mild low factor VIII. Type 2N von Willebrand disease can closely mimic hemophilia A because von Willebrand factor cannot bind factor VIII normally. Type 3 von Willebrand disease can cause very low vWF and low factor VIII with significant bleeding.
Genetic testing is useful when inherited hemophilia A is likely, when family members need testing, when a female relative has possible carrier status, or when the result affects reproductive planning. Genetic results also help some treatment decisions, including inhibitor-risk assessment in severe hemophilia A.
Testing should happen before elective surgery or dental extraction when possible. A low factor VIII result discovered after a bleeding complication still deserves complete evaluation, but earlier diagnosis gives the care team time to plan factor coverage, antifibrinolytic medicine, or other preventive treatment.
Treatment, Safety, and Practical Next Steps
Treatment depends on the cause, factor VIII level, bleeding history, procedure risk, and whether an inhibitor is present. The right plan differs for mild hemophilia A, severe hemophilia A, von Willebrand disease, and acquired hemophilia A.
For inherited hemophilia A, treatment options include factor VIII concentrate, desmopressin for selected mild cases, antifibrinolytic medicines for mucosal bleeding, and preventive therapy for people with frequent or severe bleeding. Some patients use emicizumab to prevent bleeding. People with inhibitors need specialized treatment, often with bypassing agents, emicizumab, immune tolerance therapy, or other specialist-directed regimens.
Desmopressin, also called DDAVP, helps some people with mild hemophilia A release stored factor VIII and von Willebrand factor. It does not work well enough for everyone. A supervised desmopressin challenge test is usually needed before relying on it for surgery or bleeding. It is not used for all patients because it can cause low sodium, fluid-balance problems, and other risks.
Tranexamic acid or aminocaproic acid helps stabilize clots on mucosal surfaces. These medicines are often useful for dental work, mouth bleeding, nosebleeds, and heavy menstrual bleeding. They do not replace factor treatment for dangerous deep bleeding.
Acquired factor VIII inhibitors require urgent hematology care. Treatment usually has two goals: stop active bleeding and remove the inhibitor. Bleeding control may require bypassing agents, recombinant porcine factor VIII, or other specialist-directed therapies. Inhibitor removal often uses immunosuppressive treatment. This is not a wait-and-see condition when bleeding is active or factor VIII is very low.
Practical safety steps after a low factor VIII result include:
- Tell surgeons, dentists, obstetric teams, and emergency clinicians about the result before any procedure.
- Avoid aspirin unless a clinician specifically recommends it for a stronger reason.
- Ask before using ibuprofen, naproxen, high-dose fish oil, or supplements that affect bleeding.
- Use acetaminophen for pain or fever when appropriate, while staying within safe dosing limits.
- Wear medical identification if a bleeding disorder is confirmed.
- Keep a written bleeding plan for emergency care, dental work, and surgery.
- Ask the hematology team which hospital or treatment center to use for urgent bleeding.
A low factor VIII result also affects family members. If inherited hemophilia A is confirmed, relatives may need testing even if they feel healthy. Female relatives deserve special attention because “carrier” status does not guarantee normal factor VIII or no bleeding. Some have levels in the mild hemophilia range and need procedure planning.
Special Situations
Women, girls, and people with menstrual bleeding
Low factor VIII is often missed in women and girls because heavy periods are common and bleeding symptoms get normalized. Heavy menstrual bleeding from the first periods, iron deficiency, flooding, clots larger than a coin, or bleeding through protection in under two hours deserves evaluation.
A low factor VIII result in this setting raises several possibilities: hemophilia A carrier status with low factor VIII, symptomatic hemophilia A, von Willebrand disease, platelet function disorders, or more than one cause at the same time. A normal platelet count does not rule out a clotting-factor problem. A low platelet count causes a different bleeding pattern and needs separate interpretation.
Pregnancy and childbirth
Factor VIII often rises during pregnancy, especially in the third trimester. That rise can reduce bleeding risk during delivery for some people with mild hemophilia A or carrier status, but it does not remove the need for planning. Factor VIII can fall quickly after delivery, creating risk for delayed postpartum bleeding.
Pregnant patients with known or suspected hemophilia A carrier status should have factor VIII and von Willebrand factor testing early in pregnancy and again in the third trimester. Delivery planning should involve obstetrics, anesthesia, pediatrics or neonatology, and hematology. Epidural or spinal anesthesia decisions require a safe clotting plan. The newborn’s risk also matters if the fetus could have hemophilia A.
Infants and children
In infants with a family history of hemophilia A, testing should happen before circumcision or other procedures. Umbilical cord blood can be used when collected correctly, but contaminated or clotted samples create confusion. Factor VIII levels are usually interpretable in newborns better than factor IX levels, but specialist guidance is still preferred.
Warning signs in children include large bruises from minor bumps, mouth bleeding that restarts, joint swelling, muscle swelling, prolonged bleeding after vaccines or procedures, and unusual bleeding after circumcision. Petechiae—tiny pinpoint red or purple spots—usually point more toward platelet problems than hemophilia A.
Surgery, dental work, and procedures
Elective procedures should not move forward with unexplained low factor VIII until the bleeding plan is clear. Dental extractions, tonsillectomy, colonoscopy with polyp removal, biopsies, orthopedic procedures, childbirth, and major surgery all require planning.
The procedure plan often includes target factor VIII levels, timing of factor replacement or desmopressin, antifibrinolytic therapy, local bleeding-control measures, and post-procedure monitoring. Delayed bleeding several days later is a classic problem in factor deficiencies, so the plan should cover the recovery period, not just the day of the procedure.
When the result is only slightly low
A slightly low result, such as 40% to 50%, should not cause panic, but it should not be ignored when the history suggests abnormal bleeding. Repeat testing when well, vWF testing, medication review, and a bleeding history often clarify the meaning.
The most useful question is not “Is the number barely abnormal?” The better question is “Has this person bled more than expected, or are they about to face a bleeding challenge?” A borderline value matters much more before surgery, childbirth, dental extraction, or anticoagulant treatment than it does during routine screening in a person with no bleeding history.
References
- Hemophilia A 2025 (Review)
- WFH Guidelines for the Management of Hemophilia, 3rd edition 2020 (Guideline)
- ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease 2021 (Guideline)
- Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments 2022 (Review)
- Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet Needs 2023 (Review)
- Management of pregnant women who have bleeding disorders 2023 (Review)
Disclaimer
This article is for educational use and does not replace care from a qualified clinician, hematologist, or bleeding-disorder treatment center. Low factor VIII activity needs individualized interpretation because bleeding history, von Willebrand factor levels, medications, pregnancy, and assay method can change the meaning of the result. Seek urgent medical care for head injury, uncontrolled bleeding, severe pain or swelling, black stools, blood in urine, trouble breathing, or suspected internal bleeding.
